AMAG Pharmaceuticals, Inc.
Quick facts
Phase 3 pipeline
- FCM · Hematology
FCM (ferric carboxymaltose) delivers iron directly into the bloodstream to replenish iron stores and treat iron deficiency anemia. - ferumoxytol or oral iron · Hematology
Ferumoxytol is an intravenous iron replacement therapy that works by replenishing iron stores in the body.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about AMAG Pharmaceuticals, Inc.
What is AMAG Pharmaceuticals, Inc.'s pipeline?
AMAG Pharmaceuticals, Inc. has 2 drugs in Phase 3, 1 in Phase 2, 0 in Phase 1. Late-stage candidates include FCM, ferumoxytol or oral iron.
Related
- Sector hub: All tracked pharma companies